Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Active Ulcerative Colitis
NCT00410410Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2006
- Primary completion
- Jun 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 19
01
Overview
A Phase 3 trial of abatacept in ulcerative colitis (UC), sponsored by Bristol Myers Squibb. Started Dec 2006; status: completed.
02
Drugs
abatacept
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00410410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410410.